BioVenture VoiCes with Chris Garabedian

Josh Resnick describes his career path, which includes working on the venture side of both private funds and pharma (Merck). He explains the different investment strategies of RA Capital, and talks about how the firm's Raven company building incubator fits in. Plus, his thoughts on venture investing in the current environment.

Steve Tregay describes his career path, including how early roles at Array BioPharma and Novartis led him to found Forma Therapeutics. He describes the founding and growth of LabCentral, for which he is still the chairman today, and how getting a look at entrepreneurs at such an early stage naturally led to the investment work that he and his partners do at Mission BioCapital.

Joe Jimenez describes the career path in consumer products that led him to pharma, his time running Novartis, and the idea to co-found Aditum Bio with his partner Mark Fishman. He explains Aditum's investment philosophy, and why they like focusing on translational medicine opportunities that are just heading into the clinic. Plus, his thoughts on making R&D more efficient.

Shahram describes his upbringing as a refugee from Iran, his early career in law and banking, and how his initial experience in the tech industry has benefitted his eye towards life sciences. He recalls founding Civilization Ventures with an initial $1M fund, and talks about what it has quickly grown into today, Plus, his take on AI and the current state of tech bio.

A General Partner at Flagship Pioneering, Avak describes his upbringing and studies in the Middle East and Montreal, Canada, working in industry at Helicos, and co-founding companies at Flagship since 2011. He discusses Flagship's unique platform of company building and innovation.

A Partner at Pillar VC, Tony describes his start at MIT, founding the MIT BioMakerspace, his work at Petri, being an early supporter of Nucleate, and his philosophy of not being overly influenced by what is in vogue today.

The Co-Founder and Operating Chairman of Curie. Bio, and serial entrepreneur, shares experiences from his early life, CombinatoRx, Foundation Medicine, Third Rock, EQRx and more.

He describes his career path and learnings from the tech industry, co-founding Adimab, the work that Alloy and 82VS do to support and invest in scientist-entrepreneurs, and why he believes smaller organizations are best suited for discovery work and other early stage innovation.

A general partner the firm, she describes her career path, including time spent at Goldman Sachs and Genentech, before landing at Canaan over a decade ago. She discusses the firm's investment approach to healthcare, and boldly moving into new categories of medicine even in cases where an organization doesn't have existing commercial infrastructure.

MPM's founder and managing partner discusses the firm's 30+ years of investing in life sciences, including the philosophy of placing entrepreneur partners at companies from the start, and teaming up with research institutions and investment collaborators. Plus, the keys making it through a down cycle like the industry has been in over recent years.

He describes his career path, including time in the lab and doing quant work at Goldman Sachs. Plus, what he has learned about VC investing and biotech over time, and how Omega Funds is able to successfully invest in various stages and rounds of companies.

He describes this path to venture investing from his start in science at the NIH to becoming a pathologist, and eventually raising a modest first fund and building off of its success. Plus, his investment philosophy and investing in science - including outside of therapeutics.

Sara Nayeem describes her career path and how different firms she has worked for have had different approaches to investing. She introduces us to Enavate Sciences, and shares her thoughts on investing in various areas such as rare diseases and digital health.

D.A. Wallach describes how he went from music to healthcare/biotech investing, and the similarities he sees between the two industries. Plus, the firm's investment philosophy and how he partnered with Tim Wright to create the firm.

Beth Seidenberg tells the story of how her career went from physician, to product development in industry, to investor. She describes the qualities she looks for in an entrepreneur, and discusses the Los Angeles core of Westlake BioPartners.

Bryan Roberts discusses Venrock's history, moving from NYC to the Bay Area, his investment philosophy, portfolio construction and concentration, the types of entrepreneurs he looks for, what qualities make for a good early stage investor, thoughts on AI, Tech Bio, and more.